From Roche to Poseida to CIRM: A Small Window on Cell Research and Potential Conflicts of Interest
The story was hardly more than a footnote last month for California’s $12 billion stem cell and gene therapy research program.
The article involved only a small fraction of the total that the stem cell agency has invested in seeking cures for afflictions ranging from cancer to incontinence. Not to mention that the resea…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.